PortfoliosLab logoPortfoliosLab logo
OSCR vs. BLND
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

OSCR vs. BLND - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Oscar Health, Inc. (OSCR) and Blend Labs, Inc. (BLND). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, OSCR achieves a 90.61% return, which is significantly higher than BLND's -43.75% return.


OSCR

1D
11.75%
1M
28.53%
YTD
90.61%
6M
63.72%
1Y
77.63%
3Y*
43.86%
5Y*
-0.71%
10Y*

BLND

1D
5.56%
1M
23.91%
YTD
-43.75%
6M
-46.89%
1Y
-54.28%
3Y*
20.39%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

OSCR vs. BLND - Yearly Performance Comparison


2026 (YTD)20252024202320222021
OSCR
Oscar Health, Inc.
90.61%6.92%46.89%271.95%-68.66%-59.49%
BLND
Blend Labs, Inc.
-43.75%-27.79%65.10%77.08%-80.38%-64.88%

Correlation

The correlation between OSCR and BLND is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.25

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (All Time)
Calculated using the full available price history since Jul 19, 2021

0.27

Fundamentals

Market Cap

OSCR:

$9.03B

BLND:

$437.13M

EPS

OSCR:

-$0.14

BLND:

-$0.04

PS Ratio

OSCR:

0.59

BLND:

3.49

Total Revenue (TTM)

OSCR:

$13.30B

BLND:

$127.59M

Gross Profit (TTM)

OSCR:

$895.79M

BLND:

$95.50M

EBITDA (TTM)

OSCR:

$19.23M

BLND:

-$16.09M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

OSCR vs. BLND — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OSCR
OSCR Risk / Return Rank: 7070
Overall Rank
OSCR Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
OSCR Sortino Ratio Rank: 7272
Sortino Ratio Rank
OSCR Omega Ratio Rank: 7070
Omega Ratio Rank
OSCR Calmar Ratio Rank: 7070
Calmar Ratio Rank
OSCR Martin Ratio Rank: 6767
Martin Ratio Rank

BLND
BLND Risk / Return Rank: 1212
Overall Rank
BLND Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
BLND Sortino Ratio Rank: 1212
Sortino Ratio Rank
BLND Omega Ratio Rank: 1313
Omega Ratio Rank
BLND Calmar Ratio Rank: 1212
Calmar Ratio Rank
BLND Martin Ratio Rank: 1111
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OSCR vs. BLND - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Oscar Health, Inc. (OSCR) and Blend Labs, Inc. (BLND). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


OSCRBLNDDifference
Sharpe ratioReturn per unit of total volatility

+1.76

Sortino ratioReturn per unit of downside risk

+2.77

Omega ratioGain probability vs. loss probability

1.22

0.88

+0.34

Calmar ratioReturn relative to maximum drawdown

1.51

-0.80

+2.30

Martin ratioReturn relative to average drawdown

2.80

-1.33

+4.13

OSCR vs. BLND - Sharpe Ratio Comparison

The current OSCR Sharpe Ratio is 1.00, which is higher than the BLND Sharpe Ratio of -0.76. The chart below compares the historical Sharpe Ratios of OSCR and BLND, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


OSCRBLNDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.00

-0.76

+1.76

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.01

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.06

-0.48

+0.42

Drawdowns

OSCR vs. BLND - Drawdown Comparison

The maximum OSCR drawdown since its inception was -94.15%, roughly equal to the maximum BLND drawdown of -97.37%. Use the drawdown chart below to compare losses from any high point for OSCR and BLND.


Loading charts...

Drawdown Indicators


OSCRBLNDDifference

Max Drawdown

Largest peak-to-trough decline

-94.15%

-97.37%

+3.22%

Max Drawdown (1Y)

Largest decline over 1 year

-51.71%

-68.42%

+16.71%

Max Drawdown (3Y)

Largest decline over 3 years

-53.39%

-74.21%

+20.82%

Max Drawdown (5Y)

Largest decline over 5 years

-91.82%

Current Drawdown

Current decline from peak

-25.51%

-91.82%

+66.31%

Average Drawdown

Average peak-to-trough decline

-65.12%

-81.10%

+15.98%

Ulcer Index

Depth and duration of drawdowns from previous peaks

27.80%

40.92%

-13.12%

Volatility

OSCR vs. BLND - Volatility Comparison

The current volatility for Oscar Health, Inc. (OSCR) is 25.40%, while Blend Labs, Inc. (BLND) has a volatility of 28.87%. This indicates that OSCR experiences smaller price fluctuations and is considered to be less risky than BLND based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


OSCRBLNDDifference

Volatility (1M)

Calculated over the trailing 1-month period

25.40%

28.87%

-3.47%

Volatility (6M)

Calculated over the trailing 6-month period

45.69%

54.77%

-9.08%

Volatility (1Y)

Calculated over the trailing 1-year period

78.49%

71.61%

+6.88%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

80.69%

84.43%

-3.74%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

80.06%

84.43%

-4.37%

Dividends

OSCR vs. BLND - Dividend Comparison

Neither OSCR nor BLND has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

OSCR vs. BLND - Financials Comparison

This section allows you to compare key financial metrics between Oscar Health, Inc. and Blend Labs, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B20222023202420252026
4.65B
30.84M
(OSCR) Total Revenue
(BLND) Total Revenue
Values in USD except per share items

OSCR vs. BLND - Profitability Comparison

The chart below illustrates the profitability comparison between Oscar Health, Inc. and Blend Labs, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%202220232024202520260
75.8%
Portfolio components
OSCR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Oscar Health, Inc. reported a gross profit of 0.00 and revenue of 4.65B. Therefore, the gross margin over that period was 0.0%.

BLND - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Blend Labs, Inc. reported a gross profit of 23.37M and revenue of 30.84M. Therefore, the gross margin over that period was 75.8%.

OSCR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Oscar Health, Inc. reported an operating income of 704.09M and revenue of 4.65B, resulting in an operating margin of 15.2%.

BLND - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Blend Labs, Inc. reported an operating income of -5.06M and revenue of 30.84M, resulting in an operating margin of -16.4%.

OSCR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Oscar Health, Inc. reported a net income of 679.00M and revenue of 4.65B, resulting in a net margin of 14.6%.

BLND - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Blend Labs, Inc. reported a net income of -12.78M and revenue of 30.84M, resulting in a net margin of -41.4%.


Frequently Asked Questions


OSCR and BLND have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BLND has higher volatility (28.87%) compared to OSCR (25.40%). In terms of maximum drawdown, OSCR dropped -94.15% vs BLND's -97.37%.

OSCR currently has the higher Sharpe Ratio (1.00 vs -0.76), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for OSCR and BLND

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer